Amanote Research
Register
Sign In
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)
Science-Business eXchange
doi 10.1038/scibx.2010.1204
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2010
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1); Transforming Growth Factor-Β1 (TGFB1; TGFβ1)
Science-Business eXchange
RASD Family Member 2 (RASD2; Rhes; TEM2); Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)
Science-Business eXchange
Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases
Biomedical Journal
Medicine
Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids
European Oncology and Haematology
Oncology
Hematology
Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation
Journal of Neuroscience
Neuroscience
Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
Current Neurology and Neuroscience Reports
Neuroscience
Neurology
New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists
Breast Cancer Research
Cancer Research
Oncology